Industry
Lab visits, without the lobby.
High-volume, short-visit, capacity-bound. Built for the rhythm of phlebotomy and specimen collection.
WHAT LAB OPERATORS ARE FACING
High-volume, capacity-constrained, and zero margin for friction.
Labs run on throughput and on referrals. A single bottleneck or a single missed walk-in cascades into the rest of the day — and into the relationship with the ordering provider.
12%
NO-SHOW RATE IN A LAB STUDY
A vascular laboratory study found a 12% no-show rate — translating to a gross loss of $89,107 annually for a single lab unit. Equipment is expensive and underused capacity is real money.
Source: Vascular laboratory no-show economic study
23%
GLOBAL NO-SHOW AVERAGE
Across healthcare globally, 23.5% of scheduled appointments end in no-show. For labs running on tight specimen-collection windows, that volatility is operationally crippling.
Source: Health Sci Rep systematic review, 2024
2x
ATTRITION RISK FOR CHRONIC PATIENTS
Patients managing chronic conditions are twice as likely to leave their provider after missing a single appointment. For labs serving chronic-disease populations, that's the recurring-revenue base eroding.
Source: Patient retention research
The problem in this industry
Lab volumes spike unpredictably.
A single peak hour creates a multi-hour ripple. And the patient experience — waiting standing up, blood draw, brief interaction — has no margin for friction. Every minute of perceived wait is a minute too many.
Configured for labs
Built for high volume and short, high-stakes visits.
Capacity-aware scheduling
Match patient demand to your actual phlebotomist coverage in real time.
Walk-in + appointment hybrid
Both flows in one queue. Walk-ins see honest wait estimates before they commit.
Specimen-type routing
Send each patient to the right station based on what's being collected.
Use cases
Where labs start with QLess Health.
Self-scheduling for routine draws
Walk-in queuing
Same-day capacity flexing
Result-delivery notifications
23% of US specialty appointments end in a no-show. For walk-in-driven settings, the number is the lower bound — capture and conversion are the operating margin.
Customer Story
How a 40-site lab network handled a Monday-morning surge without overflow.
Read the storyCompliance
Built to inherit your security posture.
Integrations
The lab systems we're built to work alongside.
WHAT YOU'LL SEE
What lab networks typically see.
Lab economics hinge on throughput, capacity utilization, and the relationship with ordering providers. All three move when access works.
20–40%
no-show reduction
Specimen-aware scheduling and prep-flagged reminders catch the failure modes most reminder systems miss.
15–35%
capacity utilization lift
Walk-in plus appointment hybrid scheduling lets you absorb peak demand without overflow. Fewer chairs sitting empty during slow hours; fewer patients waiting during busy ones.
$80–250K
annual recovery per lab unit
Vascular lab studies show $89K annual loss from a 12% no-show rate; recovery scales with unit count and equipment cost. The expensive equipment is the math multiplier.
Illustrative ranges based on cross-industry queue management outcomes. Healthcare-specific results vary by organization size, baseline maturity, and rollout sequencing.
Ready to give your patients back their time?
A 25-minute call. We'll show you what's possible for your team with QLess Health
Sources
- MGMA, industry surveys